How do you value BLT?
How about a tech that has consistently proven in preclinical data that it is safe and effective? How about two patients already dosed with no adverse effects and shRNA being produced? How about the confidence in the management to consider manufacturing decisions?
Benitec is not valued based on SP manipulation, but on individual investors who have done their due diligence? Even RA capital still retains Benitec stock.
Anyone that is down ramping BLT without any good information for doing so either does not understand the company and tech, or is trying to play off the manipulation of SP.
How do you value BLT? Ask me in five years.
Aussie SP holding steady..., page-15
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)